Prospective Studyによる骨シンチグラフィの臨床的有効度評価 ―臨床データの集計結果―

秋山 芳久; 油井 信春; 松本 徹; 飯沼 武; 石川 達雄; 中島 哲夫; 町田 喜久雄; 西川 潤一; 飯尾 正宏; 宇野 公一; 内山 暁; 三木 誠; 川上 憲司; 久保 敦司; 高木 八重子; 村田 啓; 日下部 きよ子; 小山田 日吉丸

doi:10.3769/radioisotopes.37.3_140

Prospective Study to Assess the Clinical Efficacy of Bone Scintigraphy

—Some analyses of clinical data—

Yoshihisa AKIYAMA, Nobuharu YUI, Toru MATSUMOTO, Takeshi IINUMA, Tatsuo ISHIKAWA, Tetsuo NAKAJIMA, Kikuo MACHIDA, Junichi NISHIKAWA, Masahiro IIO, Kimiichi UNO, Guio UCHIYAMA, Makoto MIKI, Kenji KAWAKAMI, Atsushi KUBO, Yaeko TAKAGI, Hajime MURATA, Kiyoko KUSAKABE, Hiyoshimaru OYAMADA

Author information

Yoshihisa AKIYAMA
Chiba Cancer Center Hospital
Nobuharu YUI
Chiba Cancer Center Hospital
Toru MATSUMOTO
National Institute of Radiological Science
Takeshi IINUMA
National Institute of Radiological Science
Tatsuo ISHIKAWA
Narutoh Public Hospital
Tetsuo NAKAJIMA
Saitama Cancer Center Hospital
Kikuo MACHIDA
Saitama Medical School Medical Center
Junichi NISHIKAWA
Faculty of Medicine, University of Tokyo
Masahiro IIO
Faculty of Medicine, University of Tokyo
Kimiichi UNO
School of Medicine, Chiba University
Guio UCHIYAMA
Yamanashi Medical University
Makoto MIKI
Tokyo Medical College
Kenji KAWAKAMI
Jikei University School of Medicine
Atsushi KUBO
School of Medicine, Keio University
Yaeko TAKAGI
Tokyodenryoku Hospital
Hajime MURATA
Toranomon Kyosai Hospital
Kiyoko KUSAKABE
Tokyo Woman's Medical College
Hiyoshimaru OYAMADA
National Cancer Center Hospital

Keywords: clinical efficacy, preoperative bone scan, prospective study, breast carcinoma, prostate carcinoma

JOURNAL FREE ACCESS

1988 Volume 37 Issue 3 Pages 140-147

DOI https://doi.org/10.3769/radioisotopes.37.3_140

Details

Abstract

The value of preoperative bone scans in patients with primary breast and prostate cancer was evaluated prospectively.
Of 414 patients with breast cancer, clinical stage I is 14, II is 219, IIIA is 59, IIIB is 39 and IV is 14. Of 88 patients with prostate cancer, clinical stage I is 14, II is 15, III is 18 and IV is 41. 11 percent of patients with breast cancer and 54 percent of patients with prostate cancer had bone metastases. Clavicle, ribs, thoracic spine, lumbar spine and pelvis metastasized most freqently. The incidences of bone metastases were 18.4% with Scirrhous carcinoma, 15.4% with Medullary tubular carcinoma and 3.8% with Papillotubular carcinoma.
The methodology and results of ROC analysis were described in our other papers. Some results of data analysis were described in this paper.

Corresponding author

Register with J-STAGE for free!